American Journal of Hematology
Optimizing Outcomes in Relapsed and Refractory Multiple Myeloma: personalized approaches and adverse event management
Course points: 1 - ACCME (AMA PRA)
American Journal of Hematology
Frontline therapy of acute myeloid leukemia with lower intensity regimens: Where are we now and where can we go?
Course points: 1 - ACCME (AMA PRA)
American Journal of Hematology
Maintenance Therapy in AML: What Is the Future Potential?
Course points: 1 - ACCME (AMA PRA)
American Journal of Hematology
Treatment of Relapsed/Refractory AML—Novel Treatment Options Including Immunotherapy
Course points: 1 - ACCME (AMA PRA)
American Journal of Hematology
Frontline Therapy of AML in the Fit and Younger Population—Incorporating Molecularly Targeted Agents
Course points: 1 - ACCME (AMA PRA)
American Journal of Hematology
Measurable residual disease monitoring in AML: Prospects for therapeutic decision-making and new drug development
Course points: 1 - ACCME (AMA PRA)
Login
Accessing this course requires a login. Please enter your credentials below!
